Oncotelic Therapeutics, Inc. (OTLC) — Total Assets

Annual figures by fiscal year, from SEC filings.

2010: $5.57M2011: $11.06M2012: $5.45M2013: $7.29M2014: $30.42M2015: $27.45M2016: $14.11M2017: $1.17M2018: $2.75M2019: $23.68M2020: $23.66M2021: $23.61M2022: $36.12M2023: $30.01M2024: $26.68M2025: $393.09M$393.09M
2010Total Assets (USD)2025
Fiscal YearTotal AssetsChange YoY
2025$393.09M+1373.5%
2024$26.68M-11.1%
2023$30.01M-16.9%
2022$36.12M+53.0%
2021$23.61M-0.2%
2020$23.66M-0.1%
2019$23.68M+762.0%
2018$2.75M+134.5%
2017$1.17M-91.7%
2016$14.11M-48.6%
2015$27.45M-9.8%
2014$30.42M+317.1%
2013$7.29M+33.9%
2012$5.45M-50.7%
2011$11.06M+98.6%
2010$5.57M